About Us Products in Development Patients & Caregivers Investors & Media Partnering
Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

Sunesis In The News

Aug 04 2020
Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Highlights

Jul 29 2020
Sunesis Announces Pricing of $12 Million Offering of Common Stock

Jul 28 2020
Sunesis Announces Proposed Public Offering of Common Stock

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.

With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives!



Want to learn more about
Chronic Lymphocytic Leukemia?
Please visit:
Know AML - World Awareness Day 21 April
CLLS is a patient–centric, physician–curated nonprofit organization focused on patient education, support and research dedicated to addressing the unmet needs of the CLL (chronic lymphocytic leukemia) community.
© 2020 Sunesis Pharmaceuticals, Inc. - SVR-WEB00-SYM
Contact Us | Careers | Terms of Use | Site Map